DE60033416D1 - Verwendung von hypoestoxiden als antiparasitäre mittel - Google Patents

Verwendung von hypoestoxiden als antiparasitäre mittel

Info

Publication number
DE60033416D1
DE60033416D1 DE60033416T DE60033416T DE60033416D1 DE 60033416 D1 DE60033416 D1 DE 60033416D1 DE 60033416 T DE60033416 T DE 60033416T DE 60033416 T DE60033416 T DE 60033416T DE 60033416 D1 DE60033416 D1 DE 60033416D1
Authority
DE
Germany
Prior art keywords
hypoestoxides
antiparasitic agents
insultors
theeof
nucleated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60033416T
Other languages
English (en)
Other versions
DE60033416T2 (de
Inventor
A Ojo-Amaize
I Okogun
J Nchekwube
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Paraquest Inc
Original Assignee
Paraquest Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paraquest Inc filed Critical Paraquest Inc
Application granted granted Critical
Publication of DE60033416D1 publication Critical patent/DE60033416D1/de
Publication of DE60033416T2 publication Critical patent/DE60033416T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DE60033416T 1999-07-06 2000-07-06 Verwendung von hypoestoxiden als antiparasitäre mittel Expired - Lifetime DE60033416T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US347900 1999-07-06
US09/347,900 US6242484B1 (en) 1999-07-06 1999-07-06 Hypoestoxides, derivatives and agonists thereof for use of antiparasitic agents
PCT/US2000/018596 WO2001001975A2 (en) 1999-07-06 2000-07-06 Hypoestoxides, derivatives and agonists thereof for use as antiparasitic agents

Publications (2)

Publication Number Publication Date
DE60033416D1 true DE60033416D1 (de) 2007-03-29
DE60033416T2 DE60033416T2 (de) 2007-11-29

Family

ID=23365772

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60033416T Expired - Lifetime DE60033416T2 (de) 1999-07-06 2000-07-06 Verwendung von hypoestoxiden als antiparasitäre mittel

Country Status (6)

Country Link
US (1) US6242484B1 (de)
EP (1) EP1225892B1 (de)
AT (1) ATE353642T1 (de)
AU (1) AU6076500A (de)
DE (1) DE60033416T2 (de)
WO (1) WO2001001975A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1143646A1 (de) 2000-04-05 2001-10-10 Telefonaktiebolaget Lm Ericsson Optisches Kommunikationssystem mit zwei parallelen Übertragungswegen
WO2003022266A1 (en) * 2001-08-24 2003-03-20 Paraquest, Inc. Hypoestoxides, derivatives and agonists thereof for use as inhibitors of angiongenesis
WO2004039362A2 (en) * 2002-10-28 2004-05-13 Paraquest, Inc. Hypoestoxides, derivatives and agonists thereof for use in the treatment and prophylaxis of hyperlipidemia
WO2004062590A2 (en) * 2003-01-07 2004-07-29 Kemin Pharma Europe B.V.B.A. Bicyclic carbohydrates as antiprotozoal bioactive for the treatment of infections caused by parasites
US7229979B2 (en) * 2003-06-23 2007-06-12 Immune Modulation, Inc. Hypoestoxides, derivatives and agonists thereof for use as stent-coating agents
US20050112071A1 (en) * 2003-10-23 2005-05-26 Paraquest, Inc. Hypoestoxides, derivatives, agonists and crude extracts thereof for use in cosmetic compositions
US20060094695A1 (en) * 2004-11-02 2006-05-04 Paraquest, Inc. Hypoestoxides, derivatives and agonists thereof for use in the prophylaxis and treatment of obesity
US8124654B2 (en) * 2008-11-11 2012-02-28 Immune Modulation, Inc. Derivatives of hypoestoxide and related compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801193A (en) * 1997-04-15 1998-09-01 Immune Modulation, Inc. Compositions and methods for immunosuppressing
US5994328A (en) * 1998-01-14 1999-11-30 Immune Modulation, Inc. Hypoestoxides, derivatives and agonists thereof for use as anticancer agents
US6001871A (en) * 1998-01-15 1999-12-14 Immune Modulation, Inc. Hypoestoxides, derivatives and agonists thereof for use as antiviral agents

Also Published As

Publication number Publication date
DE60033416T2 (de) 2007-11-29
AU6076500A (en) 2001-01-22
WO2001001975A2 (en) 2001-01-11
ATE353642T1 (de) 2007-03-15
EP1225892B1 (de) 2007-02-14
US6242484B1 (en) 2001-06-05
WO2001001975A3 (en) 2002-05-23
EP1225892A2 (de) 2002-07-31

Similar Documents

Publication Publication Date Title
MXPA03007140A (es) Derivados de carbolina.
DE69941429D1 (de) 1-deoxy-galactonojirimycin-derivate zur vewendung bei der behandlung von lysosomalen speicherkrankheiten mittels steigerung der lysosomalen alpha galactosidase a
DE69928952D1 (de) Chinolin-derivate und ihre verwendung als antibakterielle wirkstoffe
ATE375142T1 (de) Medizinische aerosolformulierungen
MXPA03011922A (es) Composiciones farmaceuticas que contienen un dispersion solida de un farmaco ligeramente soluble en una matriz y plimero mejorador de solubilidad.
EA200100731A1 (ru) Фенилфенантридины с ингибирующей фдэ-4 активностью
DE60131138D1 (de) Antibakterielle mittel
MY135732A (en) 5,6-trimethylenepyrimidin - 4 - one compounds
BR0207775A (pt) Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
TR200101793T2 (tr) CCR5 modülatörleri olarak azabisikloalkanlar
ATE280160T1 (de) Substituierte aryl-oder heteroarylamide mit retinoid-ähnlicher biologischer aktivität
TR200401871T4 (tr) Değiştirilen oktanoil amitlerin (octanoyl amides) hazırlanması
AU2001266575A1 (en) Chemical compounds
NO2019032I1 (no) Treosulfan
RS51478B (sr) Upotreba bradikardijskih supstanci u lečenju miokardnih oboljenja povezanih sa hipertrofijom i nove kombinacije lekova
DE60033918D1 (de) Polysubstituted 6-phenylphenanthridines mit pde-iv hemmender wirkung
DK1330258T3 (da) Kahalalid F-formulering
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
DE60033416D1 (de) Verwendung von hypoestoxiden als antiparasitäre mittel
DE60025327D1 (de) 6-arylphenanthridine mit pde-iv hemmender wirkung
SE0302129D0 (sv) Farmaceutiska kompositioner med antibiotisk aktivitet
DE60008400D1 (de) Triazolopyrimidinderivate
ATE416782T1 (de) Medizinische verwendung von il-174 agonisten und antagonisten
DE60122559D1 (de) Indolderivate als pde5-inhibitoren
EP0995430A3 (de) Verwendung von Wirkstoffen, gewählt aus der Gruppe der 1,2-Diacylglycerole, zur Stärkung der Barrierefunktion der Haut

Legal Events

Date Code Title Description
8364 No opposition during term of opposition